To support the implementation of the newly revised Provisions for Drug Registration, NMPA is currently stepping up the upgrade of related systems for drug registration. On June 11, 2020, the related issues were announced as follows:

I. On June 24, 2020, the government website of NMPA has released a new version of drug registration application software for applicants.

II. From June 28 to June 30, in order to carry out the switching and joint testing of the new and old system, NMPA and Medical Products Administration of all provinces (autonomous regions and municipalities) shall suspend the use of existing systems related to drug registration, and the corresponding drug registration acceptance and certificate issuance & delivery services will also be suspended. For emergent circumstances during this period, please contact the relevant department of NMPA.

III. From July 1, 2020, NMPA will enable a new version of related system for drug registration. Drug registrants are advised to download the latest version of the application software, and submit registration application as required.